Features of carbohydrate metabolism in asthma patients with obesity

T.V. Bezditko; G.V.  Yeryomenko

doi:10.26641/2307-0404.2022.1.254359

Автор(и)

T.V. Bezditko Kharkiv National Medical University, Nauky av., 4, Kharkiv, 61022, Україна https://orcid.org/0000-0003-1796-3877
G.V. Yeryomenko Kharkiv National Medical University, Nauky av., 4, Kharkiv, 61022, Україна https://orcid.org/0000-0001-5569-8918

DOI:

https://doi.org/10.26641/2307-0404.2022.1.254359

Ключові слова:

asthma, metabolic disorders, obesity

Анотація

Asthma (As) and metabolic disturbances are widespread and socially significant states, obesity (Ob) being also one of them. The comorbidity of As and Ob both affects physiological mechanisms of bronchial obstruction syndrome, the course and prognosis of these two diseases and significantly complicates their treatment. A combination of changes in ventilation and a complex architectonics of the bronchi may contribute to worsening control over As. The performed study deals with the problem of early diagnosis and progression of the course in patients with As and Ob comorbidity. The study involved 62 patients with As. Of them, there were 24 cases with the normal body mass (Group I) and 38 cases with As+Ob (Group II). Along with evaluation of respiratory function values and anthropometric examination, all the patients underwent controlling of carbohydrate metabolism. It was found out that As combined with Ob were accompanied by a cascade of metabolic disorders: hyperinsulinemia, insulin resistance, and higher levels of HbA1с and fasting glucose versus the control group (р<0.05). According to correlation analysis data, in Group II negative correlations between values of HOMA-IR and 40≤FEV₁<50% (r= -0.53; р<0.05), HOMA-IR and 50%≤FEV₁<60% (r= -0.49; р<0.05), insulin level and 40≤FEV₁<50% (r= -0.42; р<0.05) as well as a positive correlation between HPMA-IR value and BMI (r=0.39; р<0.05) were revealed. Patients with As, degree 1 Ob and a disorder of FEV₁>60% revealed hyperinsulinemia and an increased level of insulin resistance index; this fact can be regarded as a prognostic criterion for an improved diagnosis, prognostication of unfavorable consequences and optimization of treatment approaches. In order to detect carbohydrate metabolic disturbances in patients with As+Ob it is not enough to determine levels of glucose and glycated hemoglobin. The necessity of studying insulin resistance and insulin level for systematization and determination of development of concomitant metabolic disturbances in patients to whom iGCS are prescribed is proved.

Посилання

Konopkina LI. [Features of therapy in patients with bronchoobstructive diseases in conjunction with diabetes and obesity]. Astma ta alerhiia. 2016;4:61-62. Russian. Available from: http://www.ifp.kiev.ua/doc/journals/aa/16/pdf16-4/61.pdf

Pertseva TA. [Unresolved issues of asthma therapy]. Astma ta alerhiia. 2017;4:37-38. Russian. Available from: http://nbuv.gov.ua/UJRN/astm_2017_4_9

Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. [Internet]; 2019 [cited 2020 Apr 16]. Available from: https://ginasthma.org/wp-content/uploads/2019/06/GINA-2019-main-report-June-2019-wms.pdf

Bernhardt V, Tony GB. Exertional dyspnoea in obesity. European respiratory review. 2016;25(142):487-95. doi: https://doi.org/10.1183/16000617.0081-2016

De Santi F, Zoppini G, Locatelli F, Finocchio E, Cappa V, Dauriz M, Verlato G. Type 2 diabetes is associated with an increased prevalence of respiratory symptoms as compared to the general population. PMID: 28716044 PMCID: PMC5513377. doi: https://doi.org/10.1186/s12890-017-0443-1

Dixon AE, Peters U. The effect of obesity on lung function. Expert Rev Respir Med. 2018 Sep;12(9):755-67. doi: https://doi.org/10.1080/17476348.2018.1506331

Maniscalco M, Fuschillo S, Paris D, Cutignanob A, Sanduzzic A, Mottabet A. Clinical metabolomics of exhaled breath condensate in chronic respiratory diseases. Adv Clin Chem. 2019;88:121-49. doi: https://doi.org/10.1016/bs.acc.2018.10.002

Muc M, Mota-Pinto A, Padez C. Association between obesity and asthma – Epidemiology, pathophysiology and clinical profile. Nutr Res Rev. 2016;29(2):194-201. doi: https://doi.org/10.1017/S0954422416000111

Pradhan AD. Sex differences in the metabolic syndrome: Implications for cardiovascular health in women. Clinical Chemistry. 2014;60(1):44-52. doi: https://doi.org/10.1373/clinchem.2013.202549

Price D, Fletcher M, Van Der Molen T. Asthma control and management in 8,000 European patients: The Recognise Asthma and Link to Symptoms and Experience (REALISE) survey. NPJ Prim Care Respir Med. 2014;24:14009. doi: https://doi.org/10.1038/npjpcrm.2014.9

Sharma N, Akkoyunlu M, Rabin RL. Macrophages – common culprit in obesity and asthma. European Journal of Allergy and Clinical Immunology. 2018;73:1196-205. doi: https://doi.org/10.1111/all.13369

Sun Y, Milne S, Jaw JE, et al. BMI is associated with FEV1 decline in chronic obstructive pulmonary disease: a meta-analysis of clinical trials. Respiratory Research. 2019;20(1):236. doi: https://doi.org/10.1186/s12931-019-1209-5

Suratt BT, Ubags NDJ, Rastogi D, Tantisira KG, Marsland BJ, Petrache I, et al. An Official American Thoracic Society Workshop Report: Obesity and Metabolism. An Emerging Frontier in Lung Health and Disease. Ann Am Thorac Soc. 2017 Jun;14(6):1050-9. doi: https://doi.org/10.1513/AnnalsATS.201703-263WS